Pegasys peginterferon regulatory update

ROCZ submitted an sBLA for Pegasys peginterferon alfa-2a in combination with Copegus ribavirin to treat chronic HCV in patients co-infected with HIV. Pegasys is marketed in the U.S. to treat chronic ...